Showing results (471-480 of 532) with videos related to
Sort By:
Pageof 54
European Journal of Preventive Cardiology|October 1, 2025
Association of Neutrophil-to-Lymphocyte Ratio With Clinical Outcomes After Percutaneous Coronary InterventionAngelo Oliva, Birgit Vogel, Samantha Sartori, et al.Journal of the American College of Cardiology|June 16, 2026
Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE StudyMichael I Brener, Michael L Chuang, Raphael Nishimura, et al.European Heart Journal|January 25, 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisColette E Jackson, Davide Castagno, Aldo P Maggioni, et al.American Heart Journal|June 6, 2023
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillationSaibal Kar, Shephal K Doshi, Mohamad Alkhouli, et al.The New England Journal of Medicine|October 15, 2015
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding RiskPhilip Urban, Ian T Meredith, Alexandre Abizaid, et al.Circulation|November 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.European Heart Journal|January 9, 2021
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trialJaved Butler, Stefan D Anker, Gerasimos Filippatos, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definitionFelice Gragnano, Alessandro Spirito, Noé Corpataux, et al.BMC Medical Research Methodology|October 18, 2021
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trialsLisa J Woodhouse, Alan A Montgomery, Jonathan Mant, et al.Nature Microbiology|March 17, 2023
Hyperactive nanobacteria with host-dependent traits pervade OmnitrophotaCale O Seymour, Marike Palmer, Eric D Becraft, et al.Pageof 54